Network pharmacology analysis and clinical efficacy of the traditional Chinese medicine Bu-Shen-Jian-Pi. Part 2: Modulation of hypoxia, redox status, and mitochondrial protection in a neuroblastoma cell line, SH-SY5Y
Wenli Yuan1*, Jiacheng Lin2*, Jun Wang3, Chenghui Wang3, Yuetong Shan3, Wei Jing3, Zhimin Fei4, 5, Weidong Pan3, 5, 6
1 Department of Nephrology Diseases, Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 2 Central Laboratory, Science and Technology Laboratory Center, 3 Deparment of Neurology, 4 Department of Neurosurgery, 5 Encephalopathy Laboratory, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, and 6 First Department of Encephalopathy, Anhui Provincial Hospital of Integrated Chinese and Western Medicine (The Third Affiliated Hospital of Anhui University of Chinese Medicine), Anhui, China
DOI 10.5414/CP204505
Abstract
Objective: To examine the mitochondrial protective effects of icariin, naringenin, kaempferol, and formononetin, potentially active agents in Bu-Shen-Jian-Pi formula (BSJP) identified using network pharmacology analysis.
Materials and methods: Mitochondrial protection activity was determined using a hypoxia–reoxygenation in vitro model based on the neuroblastoma cell line SH-SY5Y and measurements of anti-ferroptotic activity.
Results: Icariin, naringenin, kaempferol, and formononetin showed mitochondrial protective activity involving diverse signaling pathways. The cytoprotective effects of formononetin depended on the inhibition of ferroptosis. Hypoxia-reoxygenation stimulation induced ferroptosis in SH-SY5Y cells.
Discussion: Ferroptosis is a key mechanism in nervous system diseases and is associated with hypoxia-reoxygenation injury. Naringenin and kaempferol were devoid of anti-ferroptotic activity.
Conclusion: Evidence has been obtained showing that the core components: icariin, naringenin, kaempferol, and formononetin in BSJP formula have anti-hypoxic and mitochondrial protective activity of potential clinical importance in the treatment of amyotrophic lateral sclerosis and patients with symptoms of hypoxia.
*Contributed equally as co-first authors.
Author Details
Authors
Departments
- 1 Department of Nephrology Diseases, Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,
- 2 Central Laboratory, Science and Technology Laboratory Center,
- 3 Deparment of Neurology,
- 4 Department of Neurosurgery,
- 5 Encephalopathy Laboratory, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, and
- 6 First Department of Encephalopathy, Anhui Provincial Hospital of Integrated Chinese and Western Medicine (The Third Affiliated Hospital of Anhui University of Chinese Medicine), Anhui, China
Address
Professor Zhimin Fei, MD
or
Professor Weidong Pan, MD, PhD
528, Pudong, New Areas
201203 Shanghai, China
Email:
[email protected]; [email protected]
Citation
Wenli Yuan, Jiacheng Lin, Jun Wang, Chenghui Wang, Yuetong Shan, Wei Jing, Zhimin Fei, Weidong Pan.Network pharmacology analysis and clinical efficacy of the traditional Chinese medicine Bu-Shen-Jian-Pi. Part 2: Modulation of hypoxia, redox status, and mitochondrial protection in a neuroblastoma cell line, SH-SY5Y
. Int J Clin Pharmacol Ther. 2024;
62:
162-
168.
doi: 10.5414/CP204505.
Pubmed:
https://pubmed.ncbi.nlm.nih.gov/38431829/;
PMID: 38431829.